Citadel Advisors
MJN

Citadel Advisors’s Mead Johnson Nutrition Company MJN Stock Holding History

Citadel Advisors’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-53,300
Closed -$4.75M – 8528
2017
Q1 		$4.75M Buy
53,300
+3,600
+7% +$296K ﹤0.01% 2098
2016
Q4 		$3.52M Sell
49,700
-6,000
-11% -$447K ﹤0.01% 2341
2016
Q3 		$4.4M Buy
55,700
+12,300
+28% +$1.05M ﹤0.01% 2107
2016
Q2 		$3.94M Sell
43,400
-64,600
-60% -$5.47M ﹤0.01% 2034
2016
Q1 		$9.18M Buy
108,000
+19,200
+22% +$1.43M 0.01% 1261
2015
Q4 		$7.01M Buy
88,800
+58,800
+196% +$4.63M 0.01% 1536
2015
Q3 		$2.11M Buy
30,000
+1,500
+5% +$123K ﹤0.01% 2868
2015
Q2 		$2.57M Sell
28,500
-2,700
-9% -$260K ﹤0.01% 2771
2015
Q1 		$3.14M Sell
31,200
-62,400
-67% -$6.29M ﹤0.01% 2532
2014
Q4 		$9.41M Sell
93,600
-24,400
-21% -$2.43M 0.01% 1444
2014
Q3 		$11.4M Buy
118,000
+8,800
+8% +$834K 0.01% 1277
2014
Q2 		$10.2M Buy
109,200
+21,100
+24% +$1.84M 0.01% 1257
2014
Q1 		$7.33M Buy
88,100
+52,300
+146% +$4.24M 0.01% 1481
2013
Q4 		$3M Sell
35,800
-30,800
-46% -$2.51M ﹤0.01% 2143
2013
Q3 		$4.95M Buy
66,600
+29,800
+81% +$2.23M 0.01% 1601
2013
Q2 		$2.92M Buy
+36,800
New +$2.95M 0.01% 2087

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Citadel Advisors's MJN Position: Q2 2017 in Review

Citadel Advisors sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 199,060 shares — an estimated $17.7M sold.

Citadel Advisors first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $202M in Q2 2015. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Citadel Advisors reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Citadel Advisors sold 199,060 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $17.7M.
  • Citadel Advisors first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Citadel Advisors's Mead Johnson Nutrition Company position peaked at $202M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.